Despite industry-like revenue growth, the lower than expecte...
Despite industry-like revenue growth, the lower than expected P/S ratio and the falling share price suggest potential risks. Some shareholders may be more bearish than recent times would indicate, accepting lower selling prices.
Market Cool On Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd's (SZSE:301126) Revenues Pushing Shares 26% Lower
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment